Integrity / innovation / cooperation / sharing / win-win
Operation mode
Corporate planning, administration, R&D, finance, procurement and management
The company focuses on building five platforms
Realize the two-way full coverage of CMC (CRO MAH CDMO) pharmaceutical R&D, manufacturing, intermediate and API procurement, production and sales industry chain. And realize the group's integrated operation through MAH.
Shanghai Union Biomedical
Industry finance capital platform with higher growth value engaged in sales, import and export of APIs and intermediates, research and development of advanced biopharmaceuticals, and research and development of intelligent medical devices.
Anhui Union Biomedical
R&D and application and registration (MAH) platform engaged in API quality research and formulation research and development, including formulation improvement, advanced and featured formulations such as controlled release preparations, compound preparations, mouth soluble membrane preparations etc.
API production platform
Advanced manufacturing platform with GMP quality system and standardized EHS system for API, advanced intermediates and small-scale production of CDMO with supporting facilitates like clean area and etc.
Intermediate production platform
Manufacturing platform with GMP quality system and standardized EHS system for advanced intermediates and small-scale production of CDMO with one hydrogenation workshop and one DCS production workshop.
-Operation mode-
CRO
Custom synthesis
CDMO
Customized production
OEM
Commissioned production
RDC
Cooperative R&D
-Production mode-
Commissioned production
Authorized production
Joint production
Self production
Follow WeChat
Anhui Union Pharmaceuticals Technology Co., Ltd.
Service line:
+86-21-54285906
E-mail:2880705932@qq.com
Add:4th Floor, Building B3, Creative Industry Park, Hefei, Anhui P. R. China.
Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.